US to start studies into three vaccine candidates from July
AstraZeneca
10,436.00p
12:54 24/12/24
0.13%
14.00p
Authorities in the US are planning to fund and conduct studies into three experimental vaccines for the novel coronavirus, including that being developed by Oxford University's Jenner institute and AstraZeneca.
Dow Jones I.A.
43,297.03
04:30 15/10/20
n/a
n/a
FTSE 100
8,136.99
12:59 24/12/24
n/a
n/a
FTSE 350
4,491.87
12:54 24/12/24
n/a
n/a
FTSE All-Share
4,449.61
13:14 24/12/24
n/a
n/a
Johnson & Johnson
$145.58
11:09 26/12/24
-0.19%
-$0.27
MODERNA
$40.43
12:44 26/12/24
0.40%
$0.16
Pharmaceuticals & Biotechnology
20,055.90
12:54 24/12/24
0.25%
50.73
According to the Wall Street Journal, which cited John Mascola, the head of vaccine research at the National Institute of Allergy and Infectious Diseases, a vaccine being manufactured by Moderna Therapeutics would come first, starting from July, followed by the Oxford vaccine in August and another vaccine candidate from Johnson&Johnson in September.